Safety and Neuroprotective Effects of Polyphenon E in MS; Phase II
Status:
Terminated
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The hypothesis is that Polyphenon E can protect brain cells in patients with Multiple
Sclerosis. To test this hypothesis we are going to compare the changes in n-Acetyl-Aspartate
(a chemical that reflects the number of neurons and their metabolism) over one year between
people with MS treated with Polyphenon E at a dose of 400mg twice a day and people with MS
treated with a matching sugar pill.
Phase:
Phase 2
Details
Lead Sponsor:
Louisiana State University Health Sciences Center in New Orleans
Collaborator:
National Center for Complementary and Integrative Health (NCCIH)